UK Council Supports Government's 'Smoke-Free Generation' Plan

Regulations by 2FIRSTS.ai
Dec.04.2023
UK Council Supports Government's 'Smoke-Free Generation' Plan
Westmorland and Furness council's health committee supports the UK government's proposed "smoke-free generation" plan to reduce smokers to under 5% by 2030.

According to Nwemail, the Health and Wellbeing Committee of the Westmorland and Furness Council in the United Kingdom has endorsed the government's proposed "smoke-free generation" plan. These measures aim to reduce the number of smokers to below 5% of the population by 2030.

 

The government's recommendations to reduce smoking include making it a criminal offense to sell tobacco products to anyone born on or after January 1st, 2009, as well as restricting the flavors and descriptions of e-cigarettes to no longer target children.

 

The government's plan also includes regulating the display of e-cigarettes in retail stores to keep them out of the sight of children and prevent them from being attracted to these products. They are also considering restrictions on the sale of disposable e-cigarettes, as this is linked to the increasing use of e-cigarettes among children.

 

Katrina Stephens, the director of public health for Westmorland and Furness Council, previously stated that smoking remains the leading cause of premature death in the region.

 

According to the UK Department of Public Health, smoking is responsible for 84% of lung cancer deaths and increases the risk of stroke by at least 50%. The government has set a target to achieve smoke-free England by 2030. This means that by 2030, the smoking population will be less than 5%.

 

According to Stephens, in order for Westmoreland and Furness to achieve this goal, 10,000 people in the region will need to quit smoking, without any new smokers starting.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Azerbaijan parliament passes third-reading amendments introducing e-cigarette penalties, effective April 1, 2026
Azerbaijan parliament passes third-reading amendments introducing e-cigarette penalties, effective April 1, 2026
Azerbaijan’s Milli Majlis has adopted, in its third reading, amendments to the Code of Administrative Offences introducing fines and confiscation for the use of e-cigarettes and their components, as well as import, export, production, wholesale and retail sales, and storage for sale.
Mar.04 by 2FIRSTS.ai
Louisiana lawmaker pushes bill to ban vape product sales within 300 feet of schools
Louisiana lawmaker pushes bill to ban vape product sales within 300 feet of schools
A Louisiana lawmaker has introduced HB 302, which would prohibit businesses from selling vapor products within 300 feet of schools. The bill would measure the distance by a person walking on the sidewalk from the nearest point on school property to the nearest point of the business. It would also give the commissioner authority to modify how the distance is calculated, while maintaining the 300-foot limit.
Feb.26 by 2FIRSTS.ai
KT&G Approves Plan to Establish Guatemala Branch as First Local Base in Central and South America
KT&G Approves Plan to Establish Guatemala Branch as First Local Base in Central and South America
KT&G has approved a plan to establish a branch in Guatemala, which will serve as its first local base in Central and South America. The company is currently preparing office space, staffing, and operating systems. KT&G said the branch is intended to secure a regional distribution base and will focus on local channel management and new sales channel expansion. Meanwhile, overseas cigarette revenue in 2025 exceeded the domestic share for the first time.
Mar.09 by 2FIRSTS.ai
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group A/S has issued notice of its annual general meeting, which will be held on April 15, 2026 at 4:30 p.m. in Copenhagen and will also be available by live webcast.
Mar.25 by 2FIRSTS.ai
Indonesia’s vape retailers adopt 21+ signage and ID verification requirements, report says
Indonesia’s vape retailers adopt 21+ signage and ID verification requirements, report says
RetailNews Asia reported that the Association of Indonesian Vape Retailers (Arvindo) has directed member stores to stop selling e-cigarettes to people under 21 and to display 21+ signage and verify customer age using valid identification.
Feb.27